GRIN Therapeutics, Inc., a leader in the development of targeted disease-specific therapies for serious neurodevelopmental disorders, today announced that it has dosed the first patient in its global ...
A large genetic screen has revealed how stem cells transform into brain cells, exposing hundreds of genes that make this ...
The study used large-scale CRISPR gene-editing technology to systematically determine which genes are required as embryonic ...
Enthorin Therapeutics, LLC, a biotechnology company focused on circuit-modulating treatments for neurological and neurodevelopmental disorders, announced that its licensing partner for MRM-3379 ...
GRIN Therapeutics begins patient dosing in global phase 3 Beeline trial of investigational radiprodil for GRINRelated neurodevelopmental disorder: New York Monday, January 12, 202 ...
Brian Lee, PhD, associate professor of epidemiology at the Dornsife School of Public Health, received a 5-year National Institutes of Health (NIH) R01 grant of $4M to study possible links between ...
Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's ...
Researchers led by a team at Baylor College of Medicine have identified a novel neurodevelopmental disorder associated with mutations or deletions affecting a gene called PAX5. Their findings are ...
Explore how stressors during pregnancy influence foetal brain development and the impact on future neurodevelopmental ...
Researchers have identified how three novel genes cause neurodevelopmental disorders. Researchers now have a better sense of the genes' roles in human brain development and function and their ability ...
As families return to school-term routines, sleep difficulties often resurface. For many parents, particularly those raising ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback